Structure-activity relationship analysis of substituted 4- quinolinamines, antagonists of immunostimulatory CpG-oligodeoxynucleotides

Bioorganic and Medicinal Chemistry Letters

Volumn 9, Issue 13, 1999, Pages 1819-1824

  Strekowski, Lucjan ^a   Zegrocka, Oliwia ^a   Henary, Maged ^a   Say, Martial ^a   Mokrosz, Maria J ^b   Kotecka, Barbara M ^c   Manzel, Lori ^d   Macfarlane, Donald E ^d  

^a GEORGIA STATE UNIVERSITY   (United States)

^b INSTITUTE OF PHARMACOLOGY   (Poland)

^c AUSTRALIAN ARMY MALARIA INSTITUTE   (Australia)

^d UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OLIGODEOXYNUCLEOTIDE; QUINOLINE DERIVATIVE;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; DRUG SYNTHESIS; IMMUNOSTIMULATION; LIPOPHILICITY; PROTON NUCLEAR MAGNETIC RESONANCE; STRUCTURE ACTIVITY RELATION;

AMINOQUINOLINES; CHLOROQUINE; CPG ISLANDS; KINETICS; OLIGONUCLEOTIDES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0033526929     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(99)00291-7     Document Type: Article

References (15)

1. 1. Macfarlane, D. E.; Manzel, L. J. Immunol. 1998, 160, 1122; and references cited therein.
2. 2. Fox, R. Semin, Arthritis Rheum. 1993, 23, 82.
3. 3. Wallace, D. J. Rheum. Dis. Clin. North Amer. 1994, 20, 243.
4. 4. Strekowski, L.; Gulevich, Y.; Baranowski, T. C.; Parker, A. N.; Kiselyov, A. S.; Lin, S.-Y.; Tanious, F. A.; Wilson, W. D. J. Med. Chem. 1996, 39, 3980.
5. 5. Strekowski, L.; Mokrosz, J. L.; Honkan, V. A.; Czarny, A.; Cegla, M. T.; Wydra, R. L.; Patterson, S. E.; Schinazi, R. F. J. Med. Chem. 1991, 34, 1739.
6. 6. Strekowski, L.; Janda, L.; Patterson, S. E.; Nguyen, J. Tetrahedron 1996, 52, 3273.
7. 7. Strekowski, L.; Zegrocka, O.; Windham, C.; Czarny, A. Org. Process Res. Dev. 1997, 1, 384.
8. 8. Strekowski, L.; Patterson, S. E.; Janda, L.; Wydra, R. L.; Harden, D. B.; Lipowska, M.; Cegla, M. T. J. Org. Chem. 1992, 57, 196.
9. 6, 75 MHz): δ 41.8, 47.5, 49.9, 54.0, 99.4, 116.3, 119.7, 120.6, 123.5, 125.1, 127.2, 127.4, 127.8, 128.5, 128.8, 129.0, 129.2, 129.4, 129.5, 131.2, 132.4, 134.2, 134.3, 138.9, 152.9, 154.7, 155.4. Spectral data for other compounds will be published in due course.
10. 10. Mokrosz, J. L.; Duszynska, B.; Strekowski, L. Pharmazie 1992, 47, 538; and references cited therein.
11. 50 value for 18 is 7600 ± 1200 nM.
12. 12. Wilson, W. D.; Ratmeyer, L.; Zhao, M.; Strekowski, L.; Boykin, D. Biochemistry 1993, 32, 4098.
13. 13. de Duve, C.; de Barsy, T.; Poole, B.; Trouet, A.; Tulkens, P.; van Hoof, F. Biochem. Pharm. 1974, 23.
14. 14. Ohkuma, S.; Poole, B. J. Cell Biol. 1981, 90, 656.
15. 15. Yi, A. K.; Tuetken, R.; Redford, T.; Waldschmidt, M.; Kirsch, J.; Krieg, A. M. J. Immunol. 1998, 160, 4755.